BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18999159)

  • 1. Polygenic model for predicting breast cancer risk via genome-wide polymorphisms.
    Piccolo SR; Camp N; Frey LJ
    AMIA Annu Symp Proc; 2008 Nov; ():1094. PubMed ID: 18999159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping.
    Ellis NA; Kirchhoff T; Mitra N; Ye TZ; Chuai S; Huang H; Nafa K; Norton L; Neuhausen S; Gordon D; Struewing JP; Narod S; Offit K
    Genet Epidemiol; 2006 Jan; 30(1):48-61. PubMed ID: 16206141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranking single nucleotide polymorphisms by potential deleterious effects.
    Lee PH; Shatkay H
    AMIA Annu Symp Proc; 2008 Nov; 2008():667-71. PubMed ID: 18999314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability to predict breast cancer in Asian women using a polygenic susceptibility model.
    Hartman M; Suo C; Lim WY; Miao H; Teo YY; Chia KS
    Breast Cancer Res Treat; 2011 Jun; 127(3):805-12. PubMed ID: 21153878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polygenic predisposition to breast cancer and the risk of coronary artery disease.
    D'Souza M; Schou M; Skals R; Weeke PE; Lee C; Smedegaard L; Madelaire C; Gerds TA; Poulsen HE; Hansen T; Grarup N; Pedersen O; Stender S; Engstrøm T; Fosbøl E; Nielsen D; Gislason G; Køber L; Torp-Pedersen C; Andersson C
    Int J Cardiol; 2019 Sep; 291():145-151. PubMed ID: 31155334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How about the uncertainty in the haplotypes in the population-based KORA studies?].
    Heid IM; Lamina C; Bongardt F; Fischer G; Klopp N; Huth C; Küchenhoff H; Kronenberg F; Wichmann HE; Illig T
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S132-6. PubMed ID: 16032531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polygenic risk prediction of common diseases: from epidemiology to clinical application].
    Jansen PR; Broeders MJM; Cornel MC; Meijers-Heijboer H
    Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.
    Yanes T; Young MA; Meiser B; James PA
    Breast Cancer Res; 2020 Feb; 22(1):21. PubMed ID: 32066492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms.
    Listgarten J; Damaraju S; Poulin B; Cook L; Dufour J; Driga A; Mackey J; Wishart D; Greiner R; Zanke B
    Clin Cancer Res; 2004 Apr; 10(8):2725-37. PubMed ID: 15102677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possibilities and limitations of genomic analyses in rheumatoid arthritis].
    Drynda S; Kekow J
    Z Rheumatol; 2009 Feb; 68(1):65-8. PubMed ID: 19145443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies.
    Evans DG; Harkness E; Lalloo F; Howell A
    J Med Genet; 2014 Sep; 51(9):573-80. PubMed ID: 25053764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of CYP17A1 and LEP Gene Polymorphisms in Breast Cancer.
    Karakus N; Kara N; Ulusoy AN; Ozaslan C; Tural S; Okan I
    Oncol Res Treat; 2015; 38(9):418-22. PubMed ID: 26407154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilizing Genetic Predisposition Score in Predicting Risk of Type 2 Diabetes Mellitus Incidence: A Community-based Cohort Study on Middle-aged Koreans.
    Park HY; Choi HJ; Hong YC
    J Korean Med Sci; 2015 Aug; 30(8):1101-9. PubMed ID: 26240488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic diversity in german and European populations: looking for substructures and genetic patterns.
    Lamina C; Steffens M; Mueller J; Lohmussaar E; Meitinger T; Wichmann HE
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S127-31. PubMed ID: 16032530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
    Antoniou AC; Pharoah PD; McMullan G; Day NE; Ponder BA; Easton D
    Genet Epidemiol; 2001 Jul; 21(1):1-18. PubMed ID: 11443730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
    Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-based prediction of breast cancer risk in the general population: a modeling study based on meta-analyses of genetic associations.
    van Zitteren M; van der Net JB; Kundu S; Freedman AN; van Duijn CM; Janssens AC
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):9-22. PubMed ID: 21212067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for XRCC4 in age at diagnosis and breast cancer risk.
    Allen-Brady K; Cannon-Albright LA; Neuhausen SL; Camp NJ
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1306-10. PubMed ID: 16835328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New genetic tests and their clinical utility for cancer screening].
    Probst-Hensch NM; Brand A
    Ther Umsch; 2013 Apr; 70(4):251-4; discussion 255-6. PubMed ID: 23535553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating cancer survival and clinical outcome based on genetic tumor progression scores.
    Rahnenführer J; Beerenwinkel N; Schulz WA; Hartmann C; von Deimling A; Wullich B; Lengauer T
    Bioinformatics; 2005 May; 21(10):2438-46. PubMed ID: 15705654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.